Yet another vaccine researcher has been caught faking research on a bogus AIDS vaccine, adding to the pattern of scientific fraud and criminality that characterizes the modern-day vaccine industry. Dr. Dong-Pyou Han from Iowa State University has resigned this week after admitting he spiked rabbit blood samples with healthy human blood to falsely show the presence of antibodies that would "prove" his AIDS vaccine worked.

The National Institutes of Health (NIH) was so convinced by the fraud that they gave Han $19 million in research funding. The NIH later found the fraud after attempting to replicate Han's work and figuring out something was terribly wrong with the research.

Over the next three years, starting within the next few weeks, new drugs are expected to come to market that will cure most patients with the virus, in some cases with a once-a-day pill taken for as little as eight weeks, and with only minimal side effects.

That would be a vast improvement over current therapies, which cure about 70 percent of newly treated patients but require six to 12 months of injections that can bring horrible side effects.

Being diagnosed with a potentially fatal disease usually triggers immediate treatment. But a growing number of people infected with hepatitis C are putting off therapy, choosing instead to roll the dice and wait for a new generation of drugs to become available.